STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $20.32 billion. The enterprise value is $21.88 billion.
| Market Cap | 20.32B |
| Enterprise Value | 21.88B |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Sep 4, 2026 |
Share Statistics
STERIS has 97.50 million shares outstanding. The number of shares has decreased by -0.48% in one year.
| Current Share Class | 97.50M |
| Shares Outstanding | 97.50M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | -0.51% |
| Owned by Insiders (%) | 0.33% |
| Owned by Institutions (%) | 100.27% |
| Float | 97.08M |
Valuation Ratios
The trailing PE ratio is 25.48 and the forward PE ratio is 18.19.
| PE Ratio | 25.48 |
| Forward PE | 18.19 |
| PS Ratio | 3.37 |
| Forward PS | 3.14 |
| PB Ratio | 2.82 |
| P/TBV Ratio | 13.99 |
| P/FCF Ratio | 21.98 |
| P/OCF Ratio | 15.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.36, with an EV/FCF ratio of 23.67.
| EV / Earnings | 27.22 |
| EV / Sales | 3.63 |
| EV / EBITDA | 13.36 |
| EV / EBIT | 19.06 |
| EV / FCF | 23.67 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.91 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.19 |
| Debt / FCF | 2.21 |
| Interest Coverage | 18.97 |
Financial Efficiency
Return on equity (ROE) is 11.39% and return on invested capital (ROIC) is 9.68%.
| Return on Equity (ROE) | 11.39% |
| Return on Assets (ROA) | 6.80% |
| Return on Invested Capital (ROIC) | 9.68% |
| Return on Capital Employed (ROCE) | 12.16% |
| Weighted Average Cost of Capital (WACC) | 8.63% |
| Revenue Per Employee | $336,595 |
| Profits Per Employee | $44,879 |
| Employee Count | 17,937 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 4.96 |
Taxes
In the past 12 months, STERIS has paid $280.80 million in taxes.
| Income Tax | 280.80M |
| Effective Tax Rate | 25.79% |
Stock Price Statistics
The stock price has decreased by -15.33% in the last 52 weeks. The beta is 0.91, so STERIS's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -15.33% |
| 50-Day Moving Average | 224.28 |
| 200-Day Moving Average | 229.30 |
| Relative Strength Index (RSI) | 33.88 |
| Average Volume (20 Days) | 622,808 |
Short Selling Information
The latest short interest is 2.44 million, so 2.51% of the outstanding shares have been sold short.
| Short Interest | 2.44M |
| Short Previous Month | 3.16M |
| Short % of Shares Out | 2.51% |
| Short % of Float | 2.52% |
| Short Ratio (days to cover) | 3.48 |
Income Statement
In the last 12 months, STERIS had revenue of $6.04 billion and earned $805.00 million in profits. Earnings per share was $8.18.
| Revenue | 6.04B |
| Gross Profit | 2.68B |
| Operating Income | 1.15B |
| Pretax Income | 1.09B |
| Net Income | 805.00M |
| EBITDA | 1.64B |
| EBIT | 1.15B |
| Earnings Per Share (EPS) | $8.18 |
Balance Sheet
The company has $482.30 million in cash and $2.04 billion in debt, with a net cash position of -$1.56 billion or -$16.02 per share.
| Cash & Cash Equivalents | 482.30M |
| Total Debt | 2.04B |
| Net Cash | -1.56B |
| Net Cash Per Share | -$16.02 |
| Equity (Book Value) | 7.22B |
| Book Value Per Share | 73.91 |
| Working Capital | 1.16B |
Cash Flow
In the last 12 months, operating cash flow was $1.29 billion and capital expenditures -$362.90 million, giving a free cash flow of $925.60 million.
| Operating Cash Flow | 1.29B |
| Capital Expenditures | -362.90M |
| Depreciation & Amortization | 491.00M |
| Net Borrowing | -4.30M |
| Free Cash Flow | 925.60M |
| FCF Per Share | $9.49 |
Margins
Gross margin is 44.42%, with operating and profit margins of 19.04% and 13.33%.
| Gross Margin | 44.42% |
| Operating Margin | 19.04% |
| Pretax Margin | 18.04% |
| Profit Margin | 13.33% |
| EBITDA Margin | 27.17% |
| EBIT Margin | 19.04% |
| FCF Margin | 15.33% |
Dividends & Yields
This stock pays an annual dividend of $2.76, which amounts to a dividend yield of 1.32%.
| Dividend Per Share | $2.76 |
| Dividend Yield | 1.32% |
| Dividend Growth (YoY) | 10.26% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 33.74% |
| FCF Payout Ratio | 29.07% |
| Buyback Yield | 0.48% |
| Shareholder Yield | 1.81% |
| Earnings Yield | 3.96% |
| FCF Yield | 4.55% |
Analyst Forecast
The average price target for STERIS is $263.13, which is 26.26% higher than the current price. The consensus rating is "Buy".
| Price Target | $263.13 |
| Price Target Difference | 26.26% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 6.68% |
| EPS Growth Forecast (3Y) | 9.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 5.44 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.44 |
| Piotroski F-Score | 7 |